Wellington Management Group’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Buy
+82,015
New +$2.21M ﹤0.01% 1592
2025
Q2
Sell
-1,857,268
Closed -$63M 2003
2025
Q1
$63M Sell
1,857,268
-263,507
-12% -$9.45M 0.01% 620
2024
Q4
$69M Buy
2,120,775
+84,405
+4% +$3.5M 0.01% 627
2024
Q3
$99.2M Sell
2,036,370
-772,998
-28% -$41.2M 0.02% 532
2024
Q2
$124M Buy
2,809,368
+194,945
+7% +$8.99M 0.02% 490
2024
Q1
$147M Buy
2,614,423
+308,032
+13% +$18.6M 0.03% 459
2023
Q4
$139M Buy
2,306,391
+962,381
+72% +$61M 0.03% 483
2023
Q3
$90.3M Sell
1,344,010
-313,841
-19% -$21.8M 0.02% 558
2023
Q2
$114M Sell
1,657,851
-99,577
-6% -$6.51M 0.02% 514
2023
Q1
$84.7M Sell
1,757,428
-55,322
-3% -$2.71M 0.02% 582
2022
Q4
$90.5M Buy
1,812,750
+159,785
+10% +$7.74M 0.02% 542
2022
Q3
$67.4M Sell
1,652,965
-955,523
-37% -$44.8M 0.01% 603
2022
Q2
$143M Sell
2,608,488
-1,330
-0.1% -$56.2K 0.03% 457
2022
Q1
$94.8M Buy
2,609,818
+332,773
+15% +$13.1M 0.02% 592
2021
Q4
$106M Buy
2,277,045
+1,684,410
+284% +$85.4M 0.02% 613
2021
Q3
$30M Buy
+592,635
New +$24.7M 0.01% 969
2020
Q4
Sell
-426,484
Closed -$13.2M 1969
2020
Q3
$13.2M Sell
426,484
-191,739
-31% -$6.46M ﹤0.01% 1030
2020
Q2
$26.3M Buy
+618,223
New +$24.2M 0.01% 863

Other funds holding LEGN

Wellington Management Group's LEGN Position: Q2 2026 in Review

Wellington Management Group opened a new position in Legend Biotech (LEGN) in Q2 2026: 82,015 shares worth $2.37M. The stake represents ﹤0.01% of the portfolio and ranks #1592 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in LEGN as recently as Q1 2025.

Wellington Management Group first reported a position in LEGN in Q2 2020 and has held it in 18 quarters since. The position peaked at $147M in Q1 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Wellington Management Group held 82,015 shares of Legend Biotech worth $2.37M as of Q2 2026.
  • Legend Biotech was a new Wellington Management Group position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1592 holding.
  • Wellington Management Group first reported a position in Legend Biotech in Q2 2020 and has held it in 18 quarters since.
  • Wellington Management Group's Legend Biotech position peaked at $147M in Q1 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.